Longitudinal serum albumin trajectories and neurological outcomes after aneurysmal subarachnoid hemorrhage
- 1Department of Neurosurgery, Changde Hospital, Xiangya School of Medicine, Central South University (The First People’s Hospital of Changde City) , , ,
Abstract
Background: Serum albumin is routinely measured after aneurysmal subarachnoid hemorrhage (aSAH), but most prognostic studies have relied on single measurements. We investigated whether longitudinal albumin patterns during the acute phase were associated with neurological outcome.
Methods: This retrospective cohort study screened 490 patients with intracranial aneurysms and 498 admissions. After restricting to the index hospitalization for strictly defined aSAH, 370 patients remained. The trajectory cohort included 318 patients with serum albumin measured within 48 h of admission and on at least three different days during days 0–14. Latent class mixed models identified albumin trajectories. The primary outcome was unfavorable neurological status at discharge (modified Rankin Scale [mRS] ≥ 3). Multivariable logistic regression, restricted cubic spline analyses, landmark analyses using early albumin windows, and multiple sensitivity analyses addressing severity, treatment modality, missing data, hospitalization duration, and latent-class uncertainty were performed.
Results: Three trajectories were identified: high-preserved (n = 90, 28.3%), high-declining (n = 148, 46.5%), and low-persistent (n = 80, 25.2%). Overall, 114 patients (35.8%) had unfavorable neurological outcomes. In the principal complete-case model (n = 258), compared with the high-preserved group, the adjusted odds ratios were 3.65 (95% CI, 1.57–8.47; p = 0.003) for the high-declining trajectory and 2.48 (95% CI, 1.02–6.02; p = 0.044) for the low-persistent trajectory (global p = 0.007). Early-window landmark analyses showed that higher day-3 and day-7 nadir albumin levels were associated with lower odds of subsequent unfavorable discharge status (OR per 1 g/L increase, 0.86 and 0.84, respectively; both p < 0.001). Treatment-stratified analyses showed no evidence of trajectory-by-treatment interaction (p = 0.453). Accounting for latent-class uncertainty yielded consistent results, although the low-persistent estimate became less precise. Adding trajectory class to the clinical model resulted in only modest improvement in discrimination (C-statistic 0.754 to 0.776).
Conclusion: Longitudinal serum albumin patterns were associated with neurological status at discharge after aSAH. However, because trajectory assignment incorporates post-baseline measurements and class separation was moderate, these trajectories should be interpreted as markers of evolving clinical course rather than validated independent predictors. Early landmark analyses improved temporal interpretation but did not eliminate residual confounding or reverse causation. As standardized 90-day mRS was unavailable, these findings should not be extrapolated to long-term functional prognosis.
Related
- Do Early Prognostic Measures Differentiate Mechanisms of ICU Death in Aneurysmal Subarachnoid Hemorrhage? An Analysis of Fatal Outcomes
- Non-aneurysmal perimesencephalic subarachnoid hemorrhage in a middle-aged female possibly triggered by Valsalva-like event and uncontrolled hypertension: a case report
- Interventional Rescue Therapy for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: 10-Year Experience
- Reverse Takotsubo Cardiomyopathy Complicated by Neurogenic Pulmonary Edema in Aneurysmal Subarachnoid Hemorrhage: A Case Report.
- Safety of Adult-dose Clazosentan in an Adolescent with Aneurysmal Subarachnoid Hemorrhage: A Case Report
BibTeX
@article{tang2026longitudinal,
title = {{Longitudinal serum albumin trajectories and neurological outcomes after aneurysmal subarachnoid hemorrhage}},
author = {Hua Tang and Yanli Tang and Siqi Wu and Qunxiang Zhang and Youwen Gong},
journal = {Frontiers in nutrition},
year = {2026},
month = oct,
doi = {10.3389/fnut.2026.1979070},
url = {https://europepmc.org/article/PMC/PMC13724443},
note = {CC BY},
}
RIS
TY - JOUR
TI - Longitudinal serum albumin trajectories and neurological outcomes after aneurysmal subarachnoid hemorrhage
AU - Hua Tang
AU - Yanli Tang
AU - Siqi Wu
AU - Qunxiang Zhang
AU - Youwen Gong
PY - 2026
DA - 2026/10/19
JO - Frontiers in nutrition
DO - 10.3389/fnut.2026.1979070
UR - https://europepmc.org/article/PMC/PMC13724443
AB - Background: Serum albumin is routinely measured after aneurysmal subarachnoid hemorrhage (aSAH), but most prognostic studies have relied on single measurements. We investigated whether longitudinal albumin patterns during the acute phase were associated with neurological outcome. Methods: This retrospective cohort study screened 490 patients with intracranial aneurysms and 498 admissions. After restricting to the index hospitalization for strictly defined aSAH, 370 patients remained. The trajectory cohort included 318 patients with serum albumin measured within 48 h of admission and on at least three different days during days 0–14. Latent class mixed models identified albumin trajectories. The primary outcome was unfavorable neurological status at discharge (modified Rankin Scale [mRS] ≥ 3). Multivariable logistic regression, restricted cubic spline analyses, landmark analyses using early albumin windows, and multiple sensitivity analyses addressing severity, treatment modality, missing data, hospitalization duration, and latent-class uncertainty were performed. Results: Three trajectories were identified: high-preserved (n = 90, 28.3%), high-declining (n = 148, 46.5%), and low-persistent (n = 80, 25.2%). Overall, 114 patients (35.8%) had unfavorable neurological outcomes. In the principal complete-case model (n = 258), compared with the high-preserved group, the adjusted odds ratios were 3.65 (95% CI, 1.57–8.47; p = 0.003) for the high-declining trajectory and 2.48 (95% CI, 1.02–6.02; p = 0.044) for the low-persistent trajectory (global p = 0.007). Early-window landmark analyses showed that higher day-3 and day-7 nadir albumin levels were associated with lower odds of subsequent unfavorable discharge status (OR per 1 g/L increase, 0.86 and 0.84, respectively; both p < 0.001). Treatment-stratified analyses showed no evidence of trajectory-by-treatment interaction (p = 0.453). Accounting for latent-class uncertainty yielded consistent results, although the low-persistent estimate became less precise. Adding trajectory class to the clinical model resulted in only modest improvement in discrimination (C-statistic 0.754 to 0.776). Conclusion: Longitudinal serum albumin patterns were associated with neurological status at discharge after aSAH. However, because trajectory assignment incorporates post-baseline measurements and class separation was moderate, these trajectories should be interpreted as markers of evolving clinical course rather than validated independent predictors. Early landmark analyses improved temporal interpretation but did not eliminate residual confounding or reverse causation. As standardized 90-day mRS was unavailable, these findings should not be extrapolated to long-term functional prognosis.
SN - 2296-861X
ER -